Most people with T2DM in the cohort used OGAs (60.1%) or insulin (combined with OGA (22.1%)) and the majority was overweight (30.2 kg/m2, SD 5.4), but well controlled as shown by a mean HbA1c level of 52 mmol/mol (6.9%). The gene discussed is INS; the disease is type 2 diabetes mellitus.